bharat biotech

Amid global shortage, Bharat Biotech to launch oral cholera vaccine

Bharat Biotech to launch Hillchol, its oral cholera vaccine, amid a global shortage. With Phase III trials completed and 200M…

May 21, 2025 23:08 IST

Bharat Biotech launches integrated Cell and Gene Therapy in India

Bharat Biotech launches integrated Cell and Gene Therapy facility in India

Dr. Raches Ella, Chief Development Officer, Bharat Biotech, spearheading this CGT initiative, said that oncology and rare diseases treatment therapies…

March 20, 2025 16:51 IST

Biovet's “BIOLUMPIVAXIN” gets certification from CDSCO. (Image Source: Pixabay)

Biovet’s LSD vaccine for dairy cattle and buffaloes gets CDSCO approval

ovet a company of Bharat Biotech Group has announced its Lumpy Skin Disease (LSD) vaccine for dairy cattle and buffaloes,…

February 10, 2025 15:16 IST

Bharat Biotech collaborates with Alopexx for broad-spectrum anti-microbial vaccine

In pre-clinical studies, targeting PNAG has shown effectiveness in preventing and treating infections caused by over 15 different pathogens, the…

September 11, 2024 18:49 IST

Bharat Biotech launches Cholera vaccine; Plans manufacturing expansion to address global shortage

HILLCHOL vaccine is administered orally on Day 0 and Day 14 and is suitable for individuals older than one year.

August 27, 2024 14:59 IST

Bharat Biotech's Rotavirus vaccine to increased risk of bowel gangrene in babies; Here's how

Bharat Biotech responds to study’s claim that Rotavirus vaccine increases risk of bowel issues in babies

Meanwhile, the company reaffirmed Rotovac’s safety, emphasising its manufacture from human rotavirus strains and not animal origins.

Updated: June 18, 2024 12:22 IST

Johns Hopkins Bloomberg School awards Dr. Krishna Ella highest Medal of Honour for exceptional work in public health

Under Dr. Ella’s leadership, Bharat Biotech is developing promising vaccines against Cholera, Malaria, Tuberculosis, Chikungunya, Zika, S. ParatyphiA, S. Typhimurium,…

May 25, 2024 18:56 IST

Bharat Biotech to collaborate with Serum Institute's subsidiary for production and supply of oral Polio vaccines

Bharat Biotech to collaborate with Serum Institute’s subsidiary Bilthoven Biologicals for production and supply of oral Polio vaccines

Through this collaboration, the companies will jointly obtain the regulatory approvals and licenses required to commercially manufacture OPVs in India…

April 2, 2024 12:59 IST

Cost of Bharat Biotech’s nasal vaccine revealed; Check details

The needle-less vaccine can be administered as a precautionary dose to adults who have been vaccinated with two doses of…

December 27, 2022 13:08 IST

Bharat Biotech, COVID-19 vaccines, Bharat Biotech booster dose, CO-WIN app, CDSCO, health news,

Bharat Biotech’s intranasal COVID-19 vaccine gets approved; To be available as booster dose soon

According to Bharat Biotech, the intranasal vaccine has several advantages because the nasal route has excellent potential for vaccination due…

December 23, 2022 11:46 IST

DCGI, Bharat Biotech, covid, covid 19, iNCOVACC, health news, covid news,

DCGI approves Bharat Biotech’s intranasal COVID booster dose for restricted use

The pharma company in its earlier statement said iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized…

November 25, 2022 19:13 IST

Covaxin, Covid, Bharat Biotech, Vaccination, Corona, Vaccine, WHO, Infection, Lifestyle, Health

50 mn doses of Covaxin set to expire early 2023 due to poor demand

Due to lack of product demand, production stoppage of Covaxin- a two dose jab, was initiated by Bharat Biotech earlier…

November 6, 2022 12:40 IST

AstraZeneca, nasal spray, COVID-19 vaccine, Bharat Biotech, Health news, pharma news,

AstraZeneca’s nasal COVID-19 vaccine fails clinical trial

Last month, India’s Health Ministry approved Bharat Biotech’s COVID-19 nasal spray vaccine while China’s CanSino Biologics Inc last month won…

October 11, 2022 15:46 IST

Bharat biotech, BBV154, Bharat Biotech intranasal vaccine, inovacc, health news, pharma news,

Bharat Biotech applies for market authorisation from DCGI for its intranasal COVID-19 vaccine

According to the company, the intranasal vaccine is a heterologous booster dose. Moreover, the vaccine development data will be submitted…

September 12, 2022 14:43 IST

covid, covid-19 vaccine, covid-19, nasal vaccine, bharat biotech

Bharat Biotech’s intranasal COVID-19 vaccine gets DCGI approval for restricted use

This vaccine candidate was evaluated in phase I, II and III clinical trials with successful results, a press release from…

September 6, 2022 20:19 IST

Clinical data disclosure critical for Bharat Biotech COVID-19 intranasal vaccine success in India: GlobalData

Even though intranasal vaccines can produce both local and systemic immunity, there can be challenges around long-lasting immunity, the company…

August 25, 2022 14:07 IST

Bharat Biotech, Rotavac, rotavirus, Bharat Biotech vaccines, health news, pharma news,

Nigeria introduces Bharat Biotech’s ROTAVAC vaccine for immunisation in children

At present, Nigeria accounts for 14 percent of all childhood rotavirus deaths globally, making it the country with the second-highest…

August 24, 2022 13:57 IST

Bharat Biotech concludes clinical trials of intranasal COVID-19 vaccine; Says it is safe and immunogenic

The vaccine maker claims that BBV154 has the double benefit of enabling faster development of variant-specific vaccines and easy nasal…

August 15, 2022 14:41 IST

Related News

Govt extended ITR AY 2025-26 deadline, but only 4.56 crore returns filed so far

New Zealand visa application, visa police certificates, visa Regional Passport Office, Indian Ministry of External Affairs, Immigration New Zealand

New Zealand issues new rules for Indian national visa applicants

China exits Pakistan’s $60 billion CPEC flagship project; Islamabad turns to ADB for funding

China exits Pakistan’s $60 billion economic corridor project; Islamabad turns to ADB for funding

If alcohol is brought into the jurisdiction of GST, the states would lose autonomy over one of their most dependable tax sources.

Will alcohol get costlier after new GST rates? Govt clarifies

Motilal Oswal stock picks, M&M share price, HDFC Life stock

Motilal Oswal’s top 3 ‘Buy’ picks after GST rate cut with upto 17% upside potential

First 25-bps CRR cut takes effect today

Policy19 min ago

RBI to cut cash reserve ratio by 25 bps, injecting Rs 60,000-70,000 crore into banks. Move will ease liquidity stress during busy season and allow for better management without disrupting other segments. Excess liquidity to be released by December through reverse repo auctions, improving bank margins.

View all shorts